Published in JAMA on April 17, 1987
Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med (1995) 2.26
AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease. Thorax (1992) 1.72
Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis (2010) 1.52
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. Clin Exp Immunol (1995) 1.45
Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev (1998) 1.26
Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi. J Clin Microbiol (1992) 1.17
Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. PLoS One (2011) 1.09
Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol (1991) 1.04
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One (2011) 1.00
A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bull World Health Organ (1998) 0.99
Pneumococcal vaccine and HIV infection: report of a vaccine failure and reappraisal of its value in clinical practice. Genitourin Med (1995) 0.96
Antibody responses in HIV infection. Clin Exp Immunol (1991) 0.90
Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals. Clin Diagn Lab Immunol (1998) 0.88
Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications. Thorax (1990) 0.85
Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis. Am J Public Health (2009) 0.85
A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults. Can J Infect Dis Med Microbiol (2008) 0.81
Prevention of lung infections associated with human immunodeficiency virus infection. Thorax (1989) 0.81
Response to influenza immunisation in asymptomatic HIV infected men. Genitourin Med (1995) 0.79
Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability. AIDS (2011) 0.79
Preventing secondary infections among HIV-positive persons. Public Health Rep (1991) 0.76
Long-term management after splenectomy. Consider HIV infection in thrombocytopenia. BMJ (1994) 0.75
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol (1999) 10.41
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet (1987) 4.33
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73
Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66
Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med (1992) 3.32
Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Complications of smallpox vaccination, 1968. N Engl J Med (1969) 3.08
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
Clinical forms of gonococcal arthritis. N Engl J Med (1968) 2.58
Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2001) 2.51
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1990) 2.50
The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49
Opportunistic lung infection due to "Pittsburgh Pneumonia Agent". N Engl J Med (1979) 2.49
New bacterial agent of pneumonia isolated from renal-transplant recipients. Lancet (1979) 2.45
Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med (1989) 2.44
Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis (1980) 2.41
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother (2001) 2.41
The pathophysiology of malaria. Adv Parasitol (1992) 2.33
Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis (1977) 2.30
Variables influencing condom use in a cohort of gay and bisexual men. Am J Public Health (1988) 2.26
Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization. Am J Epidemiol (1978) 2.19
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1988) 2.18
Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis (1986) 2.18
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
Viability and recovery of peripheral blood mononuclear cells cryopreserved for up to 12 years in a multicenter study. Clin Diagn Lab Immunol (1999) 2.11
A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity. J Infect Dis (1972) 2.06
Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun (1995) 2.05
Efficacy of cutting balloon angioplasty for lesions at the ostium of the coronary arteries. J Invasive Cardiol (1999) 2.04
Viral infections in renal transplant recipients. Infect Immun (1976) 2.03
Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med (1998) 2.02
Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00
Sexual transmission efficiency of hepatitis B virus and human immunodeficiency virus among homosexual men. JAMA (1990) 2.00
Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis (1970) 2.00
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med (1997) 1.98
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.91
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet (1991) 1.89
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
Difficult thoracic lesions: CT-guided biopsy experience in 150 cases. Radiology (1988) 1.87
Malaria in splenectomized patients: report of four cases and review. Clin Infect Dis (1993) 1.85
AIDS prevention in homosexual and bisexual men: results of a randomized trial evaluating two risk reduction interventions. AIDS (1989) 1.80
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. J Infect Dis (2000) 1.71
Virus infections after transplantation in man. Brief review. Arch Virol (1977) 1.70
Replication of herpes simplex virus and cytomegalovirus in human leukocytes. J Immunol (1978) 1.69
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A (1996) 1.68
No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr (1990) 1.67
Behavioral, health and psychosocial factors and risk for HIV infection among sexually active homosexual men: the Multicenter AIDS Cohort Study. Am J Public Health (1991) 1.67
Reactivation of murine cytomegalovirus by cyclophosphamide. Nature (1977) 1.67
Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology (1993) 1.67
Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis (1990) 1.67
Follow-up study: protective immunization in the elderly. Am J Public Health (1983) 1.66
The HIV antibody test: why gay and bisexual men want or do not want to know their results. Public Health Rep (1987) 1.62
Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med (1979) 1.61
Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J Infect Dis (2000) 1.61
Interferon. Annu Rev Microbiol (1975) 1.61
Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol (1991) 1.57
Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. Virology (1998) 1.57
Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody. J Virol (1989) 1.55
V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. Urology (2001) 1.54
Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood (2000) 1.54
Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun (1973) 1.54
Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1. J Biol Chem (1997) 1.53
Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50
Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infect Immun (1980) 1.50
Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS) Am J Epidemiol (1996) 1.50
Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1994) 1.47
Serum vitamin D metabolites in very low birth weight infants with and without rickets and fractures. J Pediatr (1989) 1.47
Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 1.46
Efficacy of cutting balloon angioplasty for in-stent restenosis: an intravascular ultrasound evaluation. J Invasive Cardiol (2001) 1.46
Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis (1979) 1.46
McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol (2001) 1.45